Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial.
Kitahiro Y, Yamamoto K, Yakushijin K, Ioroi T, Tanda M, Itohara K, Omura T, Minami H, Yano I. Kitahiro Y, et al. Among authors: ioroi t. JMIR Res Protoc. 2024 Feb 22;13:e54882. doi: 10.2196/54882. JMIR Res Protoc. 2024. PMID: 38386393 Free PMC article.
Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.
Yamamoto K, Shinomiya K, Ioroi T, Hirata S, Harada K, Suno M, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Bito T, Nishigori C, Miyake H, Fujisawa M, Hirai M. Yamamoto K, et al. Among authors: ioroi t. Target Oncol. 2016 Feb;11(1):93-9. doi: 10.1007/s11523-015-0382-9. Target Oncol. 2016. PMID: 26300443
STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.
Yamamoto K, Ioroi T, Kanaya K, Shinomiya K, Komoto S, Hirata S, Harada K, Watanabe A, Suno M, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Miyake H, Fujisawa M, Hirai M. Yamamoto K, et al. Among authors: ioroi t. Med Oncol. 2016 Mar;33(3):24. doi: 10.1007/s12032-016-0733-0. Epub 2016 Jan 30. Med Oncol. 2016. PMID: 26833481
Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients.
Watanabe A, Yamamoto K, Ioroi T, Hirata S, Harada K, Miyake H, Fujisawa M, Nakagawa T, Yano I, Hirai M. Watanabe A, et al. Among authors: ioroi t. Biol Pharm Bull. 2017;40(4):458-464. doi: 10.1248/bpb.b16-00875. Biol Pharm Bull. 2017. PMID: 28381801 Free article.
Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.
Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, Ebisawa K, Nagata M, Ohji G, Nakamura T, Koike C, Kusuki M, Ioroi T, Mukai A, Abe Y, Yoshida H, Hirai M, Arakawa S, Yano I, Iwata K, Tokimatsu I. Kimura T, et al. Among authors: ioroi t. Infection. 2018 Apr;46(2):215-224. doi: 10.1007/s15010-017-1099-8. Epub 2017 Nov 13. Infection. 2018. PMID: 29134582
Safety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial.
Yamamoto K, Ioroi T, Harada K, Nishiyama S, Nishigori C, Yano I. Yamamoto K, et al. Among authors: ioroi t. JMIR Res Protoc. 2019 Aug 12;8(8):e14636. doi: 10.2196/14636. JMIR Res Protoc. 2019. PMID: 31407671 Free PMC article.
Efficacy of pharmacists’ assessment and intervention based on Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese compared with Screening Tool of Older Persons' potentially inappropriate Prescriptions criteria version 2 in older patients with cardiovascular disease.
Kimura T, Ogura F, Kukita Y, Takahashi T, Yamamoto K, Ioroi T, Yano I. Kimura T, et al. Among authors: ioroi t. Geriatr Gerontol Int. 2019 Nov;19(11):1101-1107. doi: 10.1111/ggi.13773. Geriatr Gerontol Int. 2019. PMID: 31746526
STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma.
Yamamoto K, Ioroi T, Shinomiya K, Yoshida A, Harada K, Fujisawa M, Omura T, Ikemi Y, Nakagawa S, Yonezawa A, Ogawa O, Matsubara K, Iwamoto T, Nishikawa K, Hayashi S, Tohara D, Murakami Y, Motoshima T, Jono H, Yano I. Yamamoto K, et al. Among authors: ioroi t. Oncol Res. 2022 May 4;29(1):11-23. doi: 10.3727/096504022X16418911579334. Epub 2022 Jan 11. Oncol Res. 2022. PMID: 35016744 Free PMC article.
57 results